date:Jul 07, 2012
side-effects was also a key selling point.
Diabetes tackling the surging rates
The International Diabetes Federation has forecast incidence rates will rise from 240m in 2007 to 380m in 2025, with 60% coming from Asia.
Dexa Laboratories noted thatstandardised herbal drugs that have been used as anti-diabetics are still rare. Clinically proven safe and effective herbal anti-diabetic medicines are even scarcer.This, it said, was what prompted its development of Inlacin.
Work is underway to gai